Congenital and postnatal CMV and EBV acquisition in HIV-infected Zimbabwean infants

Hlanai Gumbo1, Bernard Chasekwa1, James A Church2

  • 1Zvitambo Institute for Maternal and Child Health Research, Harare, Zimbabwe.

Plos One
|December 19, 2014
PubMed

Insights

Cytomegalovirus (CMV) and Epstein Barr virus (EBV) co-infections are common in HIV-infected infants in sub-Saharan Africa. However, neither CMV nor EBV co-infection was found to increase mortality in these infants.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Virology

Background:

  • HIV-infected infants in sub-Saharan Africa experience rapid disease progression.
  • Co-infection with cytomegalovirus (CMV) or Epstein Barr virus (EBV) was hypothesized to increase mortality in this vulnerable population.

Purpose of the Study:

  • To investigate the prevalence of CMV and EBV co-infections in HIV-infected infants.
  • To determine the impact of CMV and EBV co-infections on mortality in HIV-infected infants.

Main Methods:

  • Real-time PCR was used to test 257 antiretroviral therapy-naïve HIV-infected infants for CMV and EBV at 6 weeks of age.
  • Birth samples were analyzed when available to differentiate congenital from postnatal infections.
  • Kaplan-Meier and Cox proportional hazards models were employed to assess mortality risk associated with co-infections up to 6 months of age.

Main Results:

  • By 6 weeks, 79% of infants were CMV-positive, with 11% having congenital CMV and 42% having postnatal CMV.
  • By 6 months, postnatal CMV infection showed no significant increase in mortality (aHR 1.1; 95% CI 0.6, 2.2).
  • By 6 weeks, 13% of infants had EBV co-infection, with 2% congenital and 7% postnatal; neither was associated with increased mortality by 6 months (aHR 0.8; 95% CI 0.3, 2.3).

Conclusions:

  • The majority of HIV-infected infants acquired CMV by 6 weeks, and EBV co-infection occurred earlier than anticipated.
  • A high prevalence of congenital CMV and the identification of congenital EBV infection (newly reported in Africa/HIV context) were observed.
  • Neither CMV nor EBV co-infection demonstrated a statistically significant association with increased mortality in HIV-infected infants within the study period.
Abstract

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
73
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
3.7K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
1.6K
Viral Mutations00:36

Viral Mutations

A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
41.1K
Sexually Transmitted Infections01:26

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
1.8K